ANNEXON, INC.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Annexon is based out of South San Francisco. Annexon, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. The firm last filed a Form D notice of exempt offering of securities on 2020-07-16. The notice included securities offered of Equity

Create Alert

Contact Info

annexon, inc.
180 KIMBALL WAY
SOUTH SAN FRANCISCO CA    94080

Business Phone: (650)-822-5500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-07-16 D BIOTECHNOLOGY Equity 101,999,983 101,999,983 0
2018-12-19 D BIOTECHNOLOGY Equity 84,999,985 44,999,994 39,999,991
2011-08-22 D OTHER HEALTH CARE Equity 999,999 999,999 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARNON ROSENTHAL subscription required
    DIRECTOR
BEN BARRES subscription required
    DIRECTOR
CAMPBELL MURRAY subscription required
    DIRECTOR
CAROL GALLAGHER subscription required
    DIRECTOR
DOUGLAS LOVE subscription required
    EXECUTIVE OFFICER DIRECTOR
EMMETT CUNNINGHAM subscription required
    DIRECTOR
JENNIFER LEW subscription required
    EXECUTIVE OFFICER
JUNG E. CHOI subscription required
    DIRECTOR
MARK L SMITH subscription required
    EXECUTIVE OFFICER
MUNEER SATTER subscription required
    DIRECTOR
RICKY SUN subscription required
    DIRECTOR
SANJAY KESWANI subscription required
    EXECUTIVE OFFICER
STACIE WENINGER subscription required
    DIRECTOR
TED YEDNOCK subscription required
    EXECUTIVE OFFICER
THOMAS WIGGANS subscription required
    DIRECTOR
WILLIAM YOUNG subscription required
    DIRECTOR

Elevate your investments